![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Middle East and Africa Virus-like Particles Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Hepatitis, Cancer/HPV, and Gaucher disease), Source (Yeast, Insect Cell, Plant, and Others), and Application (Vaccines and Therapeutics)
Market Introduction
The United Arab Emirates (UAE), Saudi Arabia and South Africa are the major countries in the Middle East & Africa region. Saudi Arabia was the largest market for virus-like particles in this region in 2021. The market for virus-like particles in the Middle East & Africa Saudi Arabia is anticipated to grow at higher CAGR during the forecast period; this growth is attributed to the rising prevalence of various diseases and increasing government initiatives in terms of funding and healthcare related policies.
Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries like Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in a deep economic recession due to the US sanctions. Additionally, tightened financial condition is also decreasing the economic activities in the region. Many countries are facing a shortage of COVID19 vaccines in the region. Various developing developed countries in the regions are lagging for the supplies of COVID19 vaccines. Thus, it is potential for global vaccines manufacturers to explore the untapped section of Middle East Africa. For instance, as per the data published in the Brookings Institution in August 2021, the vaccination in low- and middle-income countries in the Middle East Africa was estimated at Jordan 25% and Morocco 27%, no country in Middle East Africa has been able to provide more than 15% of their populations with one dose of the vaccine. Thus, offers a potential market for the VLP related market in the region and positively impacts the VLP market in the region.
Get more information on this report :
Market Overview and Dynamics
The virus-like particles market in Middle East & Africa is expected to grow from US$ 152.83 million in 2021 to US$ 249.12 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. Various players in the healthcare market and research organizations are actively involved in product innovations and developments. The use of virus-like particles is an emerging approach used in the biopharmaceuticals industry. As virus-like particles lack the viral content, they are easier to handle than the actual viral components. The VLPs can be used for aiding drug delivery, imaging, immunotherapy, and theragnostic. For instance, as per a study published in the NCBI in June 2020, VLP can be used in the form of nanoparticles in applications such as photothermal therapy, PET and CT imaging, MRI contrast agent carriers, optical imaging, inflammatory and autoimmune disease vaccines, cancer immunotherapy, and small molecule drug delivery (in cancer therapy). Thus, such potential applications of VLPs are expected to provide growth opportunities to market players during the forecast period.
Key Market Segments
In terms of product type, the hepatitis segment accounted for the largest share of the Middle East & Africa virus-like particles market in 2021. In terms of source, the yeast segment accounted for the largest share of the Middle East & Africa virus-like particles market in 2021. In term of application, vaccines segment held a larger market share of the virus-like particles market in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the virus-like particles market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Serum Institute of India Pvt. Ltd.; BHARAT BIOTECH; LG Chem; and VBI Vaccines Inc. among others.
Reasons to buy report
- To understand the Middle East & Africa virus-like particles market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East & Africa virus-like particles market
- Efficiently plan M&A and partnership deals in Middle East & Africa virus-like particles market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East & Africa virus-like particles market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Middle East & Africa region.
Middle East & Africa Virus-like Particles Market Segmentation
Middle East & Africa Virus-like Particles Market – By Product type
- Hepatitis
- Cancer/HPV
- Gaucher Disease
Middle East & Africa Virus-like Particles Market – By Source
- Yeast
- Insect Cell
- Plant
- Others
Middle East & Africa Virus-like Particles Market – By Application
- Vaccines
- Therapeutics
Middle East & Africa Virus-like Particles Market – By Country
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
Middle East & Africa Virus-like Particles Market – Companies Mentioned
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH
- LG Chem
- VBI Vaccines Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Virus-like Particles Market – By Product Type
1.3.2 Middle East & Africa Virus-like Particles Market – By Source
1.3.3 Middle East & Africa Virus-like Particles Market – By Application
1.3.4 Middle East & Africa Virus-like Particles Market – By Country
2. Middle East & Africa Virus-like Particles Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Virus-like Particles Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. Middle East & Africa Virus-like Particles Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Higher Prevalence of Infectious Viral Diseases
5.1.2 Fostering Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2 Market Restraints
5.2.1 Existence of Alternative Technologies for Viral Vaccine Production
5.3 Market Opportunities
5.3.1 Increasing Potential Applications in Therapeutics and Diagnostics
5.4 Future Trends
5.4.1 Regular Demand for Innovative and Effective Products
5.5 Impact Analysis
6. Middle East & Africa Virus-like Particles Market Analysis
6.1 Middle East & Africa Virus-like Particles Market Revenue Forecast and Analysis
7. Middle East & Africa Virus-like Particles Market Analysis – by Product Type
7.1 Overview
7.2 Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3 Hepatitis
7.3.1 Overview
7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer/ Human Papillomavirus (HPV)
7.4.1 Overview
7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5 Gaucher Disease
7.5.1 Overview
7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Virus-like Particles Market Analysis – By Source
8.1 Overview
8.2 Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3 Yeast
8.3.1 Overview
8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4 Plant
8.4.1 Overview
8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5 Insect Cell
8.5.1 Overview
8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Virus-like Particles Market Analysis – By Application
9.1 Overview
9.2 Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
9.3 Vaccines
9.3.1 Overview
9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4 Therapeutics
9.4.1 Overview
9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Virus-like Particles Market – Country Analysis
10.1 Overview
10.1.1 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.1.1.1 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.1.1.1.5 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.1.1.2.5 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.1.1.3.5 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Middle East & Africa Virus-like Particles Market
11.1 Impact Assessment of COVID-19 Pandemic
12. Middle East & Africa Virus-like Particles Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Merck & Co., Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sanofi
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Serum Institute of India Pvt. Ltd.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BHARAT BIOTECH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 LG Chem
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 VBI Vaccines Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 3. UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 7. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)
Table 9. South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 14. Organic Developments Done by Companies
Table 15. Inorganic Developments Done by Companies
Table 16. Glossary of Terms: Virus-like Particles Market
LIST OF FIGURES
Figure 1. Middle East & Africa Virus-like particles Market Segmentation
Figure 2. Middle East & Africa Virus-like particles Market Segmentation, By Country
Figure 3. Middle East & Africa Virus-like Particles Market Overview
Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Middle East & Africa Virus-like particles Market
Figure 5. Saudi Arabia to Show Significant Growth during Forecast Period
Figure 6. Middle East & Africa Virus-like Particles Market, Industry Landscape
Figure 7. Middle East & Africa PEST Analysis
Figure 8. Middle East & Africa Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Virus-like Particles Market– Revenue Forecast and Analysis to 2028
Figure 10. Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 23. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 24. UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Impact Of COVID-19 Pandemic in Middle East & African Countries
- Merck & Co., Inc.
- GlaxoSmithKline plc.
- Pfizer Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.
- BHARAT BIOTECH
- LG Chem
- VBI Vaccines Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa virus-like particles market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution